Glucosyl hesperidin prevents influenza A virus replication in vitro by inhibition of viral sialidase

DOI Web Site Web Site PubMed 被引用文献6件 参考文献31件 オープンアクセス
  • Saha Repon Kumer
    Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka Global COE Program for Innovation in Human Health Sciences
  • Takahashi Tadanobu
    Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka Global COE Program for Innovation in Human Health Sciences
  • Suzuki Takashi
    Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka Global COE Program for Innovation in Human Health Sciences

書誌事項

タイトル別名
  • Glucosyl Hesperidin Prevents Influenza A Virus Replication <i>in Vitro</i> by Inhibition of Viral Sialidase

この論文をさがす

説明

Hesperidin, a flavonoid obtained from citrus fruits, is known to have multiple biological activities and antimicrobial activities for human viruses; however, hesperidin has very low solubility in water and the target molecule of hesperidin for influenza virus remains unknown. A water-soluble derivative of hesperidin, glucosyl hesperidin (GH), which was synthesized by regioselective transglycosylation with cyclodextrin glucanotransferase, has been reported to have biological activities that are as or stronger than those of hesperidin. To determine the inhibitory effect of GH on influenza A virus (IAV) infection, Madin–Darby canine kidney (MDCK) cells were treated with GH before, at the same time as, and after IAV inoculation. GH treatment before IAV inoculation had no effect on virus replication, whereas, treatment with GH at the same time as or after IAV inoculation induced distinct reduction in IAV replication. Inhibition analysis of GH against two surface glycoprotein spikes of IAV revealed that GH prevents IAV replication by inhibition of viral sialidase activity that is involved in the entry and release stages on IAV infection but not by receptor binding inhibition. GH had no cytotoxic effects on MDCK cells in a dose range of 0—25 mM. Our results provide useful information for the development of novel sialidase inhibitors for influenza prevention.

収録刊行物

被引用文献 (6)*注記

もっと見る

参考文献 (31)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ